European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community list of not active medicinal products for human use |
EXPIRED |
Product information |
| Invented name: | Trazec |
| Auth. number : | EU/1/01/175 |
| INN : | nateglinide |
| ATC: | A - Alimentary tract and metabolism A10 - Drugs used in diabetes A10B - Blood glucose lowering drugs, excluding insulins A10BX - Other oral blood glucose lowering drugs A10BX03 - Nateglinide (See WHO ATC Index) |
| Indication: | Diabete type 2 |
| Marketing Authorisation Holder: | Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EPAR and active package presentations
Package presentations
|
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 05/04/2001 | Centralised - Authorisation | EMEA/H/C/383 | (2001)825 of 03/04/2001 | |||
| 26/06/2001 | Centralised - Variation | EMEA/H/C/383/I/1 | ||||
| 29/05/2002 | Centralised - Variation | EMEA/H/C/383/I/4, 5 | ||||
| 21/06/2002 | Centralised - Variation | EMEA/H/C/383/I/3 | ||||
| 15/07/2002 | Centralised - Variation | EMEA/H/C/383/I/2 | (2002)2734 of 11/07/2002 | |||
| 05/09/2002 | Centralised - Variation | EMEA/H/C/383/I/6 | (2002)3323 of 30/08/2002 | |||
| 14/10/2002 | Centralised - Variation | EMEA/H/C/383/I/7 | ||||
| 16/01/2004 | Centralised - Variation | EMEA/H/C/383/II/8 | (2004)87 of 14/01/2004 | |||
| 01/04/2004 | Centralised - Variation | EMEA/H/C/383/IB/9 | ||||
| 29/04/2004 | Centralised - Variation | EMEA/H/C/383/IB/10 | ||||
| 16/06/2004 | Centralised - Variation | EMEA/H/C/383/N/12 | ||||
| Updated with Decision(2004)3059 of 02/08/2004 | ||||||
| 04/08/2004 | Centralised - Variation | EMEA/H/C/383/II/11 | (2004)3059 of 02/08/2004 | |||
| 11/11/2004 | Centralised - Variation | EMEA/H/C/383/IA/13 | ||||
| 08/09/2005 | Centralised - Variation | EMEA/H/C/383/II/14 | (2005)3437 of 05/09/2005 | |||
| 26/04/2006 | Centralised - Renewal | EMEA/H/C/383/R/15 | (2006)1754 of 24/04/2006 | |||
| 17/07/2006 | Centralised - Variation | EMEA/H/C/383/II/16 | (2006)3291 of 13/07/2006 | |||
| 24/07/2007 | Centralised - Variation | EMEA/H/C/383/N/17 | ||||
| 20/11/2008 | Centralised - Withdrawal | - |